Jupiter Endovascular today announced the first U.S. patient treated in its SPIRARE II U.S. pivotal study for the Vertex system. The first U.S. patient treated follows last month's announcement of the first Vertex use in the SPIRARE I study in Poland. SPIRARE II evaluates the Vertex pulmonary embolectomy system in the treatment of acute pulmonary … [Read more...] about Jupiter Endovascular reports first patient treated in U.S. study of Vertex pulmonary embolectomy system
Jupiter Endovascular
Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
Jupiter Endovascular today announced the first two patients treated in a study of its Vertex pulmonary embolectomy system. Investigators treated two patients in the SPIRARE I study of the Vertex system using the company's Endoportal Control platform technology. Dr. Grzegorz Kopec, Dr. Jakub Stepniewski, and Dr. Krzysztof Bartus performed the … [Read more...] about Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
FDA grants IDE for Jupiter Endovascular’s pulmonary embolectomy system
Jupiter Endovascular announced today that the FDA approved an investigational device exemption (IDE) study for its Vertex system. The company can now conduct the SPIRARE II U.S. pivotal study for the pulmonary embolectomy system. Menlo Park, California-based Jupiter Endovascular only just came out of stealth mode, spinning out of Neptune Medical … [Read more...] about FDA grants IDE for Jupiter Endovascular’s pulmonary embolectomy system
